Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

Aimin Jiang; Wangxiao He; Yu Yao

doi:10.3389/fonc.2024.1406244

Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine

Front Oncol. 2024 Apr 5:14:1406244. doi: 10.3389/fonc.2024.1406244. eCollection 2024.

Authors

Aimin Jiang¹, Wangxiao He^{1

2}, Yu Yao¹

Affiliations

¹ Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
² Department of Talent Highland, The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China.

No abstract available

Keywords: cancer; immune checkpoint inhibitors; immunotherapy; nanomedicine; tumor immune microenvironment.

Publication types

Editorial

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China [82002437], the Huilan-Haosen Lung Cancer Precision Medicine Research Fund [HL-HS2020-124], the Innovation Capability Support Program of Shaanxi (No.2021TD-44), and the CSCO-Hengrui Tumor Research Fund [Y-HR2019-0401].